LEPROTL1
Basic information
Region (hg38): 8:30095408-30177208
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LEPROTL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 3 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 3 | 0 | 0 |
Variants in LEPROTL1
This is a list of pathogenic ClinVar variants found in the LEPROTL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-30101903-A-G | not specified | Uncertain significance (Jan 04, 2022) | ||
8-30104300-C-A | not specified | Uncertain significance (Apr 01, 2024) | ||
8-30104353-A-G | not specified | Uncertain significance (Nov 10, 2024) | ||
8-30104400-G-A | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 01, 2020) | ||
8-30104437-T-C | not specified | Uncertain significance (Jun 16, 2023) | ||
8-30131945-A-G | Benign (Jul 29, 2018) | |||
8-30131968-G-A | not specified | Likely benign (Dec 14, 2021) | ||
8-30132091-T-C | not specified | Uncertain significance (Mar 20, 2023) | ||
8-30132094-G-A | not specified | Uncertain significance (Nov 19, 2024) | ||
8-30132101-C-T | not specified | Uncertain significance (May 30, 2024) | ||
8-30132128-T-C | not specified | Uncertain significance (Sep 28, 2021) | ||
8-30132133-G-A | not specified | Uncertain significance (May 05, 2022) | ||
8-30132206-C-T | not specified | Uncertain significance (Aug 20, 2024) | ||
8-30132214-A-G | not specified | Uncertain significance (Jun 07, 2024) | ||
8-30132393-G-A | Benign (Feb 08, 2018) | |||
8-30132423-A-T | Likely benign (Apr 26, 2018) | |||
8-30132445-G-A | not specified | Uncertain significance (Jul 17, 2024) | ||
8-30132580-C-T | not specified | Uncertain significance (Oct 14, 2023) | ||
8-30132594-G-A | Likely benign (Sep 01, 2022) | |||
8-30132640-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
8-30132676-C-T | not specified | Uncertain significance (Sep 12, 2024) | ||
8-30132685-C-T | Benign (Jun 19, 2018) | |||
8-30132718-C-G | not specified | Uncertain significance (Dec 27, 2023) | ||
8-30132760-G-A | not specified | Uncertain significance (Aug 04, 2023) | ||
8-30132787-A-G | not specified | Uncertain significance (Feb 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LEPROTL1 | protein_coding | protein_coding | ENST00000523116 | 4 | 81811 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.721 | 0.267 | 116475 | 0 | 1 | 116476 | 0.00000429 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.942 | 65 | 90.2 | 0.721 | 0.00000444 | 1069 |
Missense in Polyphen | 13 | 29.644 | 0.43854 | 358 | ||
Synonymous | 0.424 | 32 | 35.2 | 0.909 | 0.00000196 | 363 |
Loss of Function | 1.90 | 0 | 4.21 | 0.00 | 1.75e-7 | 65 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000923 | 0.00000923 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Negatively regulates growth hormone (GH) receptor cell surface expression in liver. May play a role in liver resistance to GH during periods of reduced nutrient availability. {ECO:0000269|PubMed:19907080}.;
Recessive Scores
- pRec
- 0.0924
Intolerance Scores
- loftool
- 0.454
- rvis_EVS
- 0.48
- rvis_percentile_EVS
- 79.04
Haploinsufficiency Scores
- pHI
- 0.262
- hipred
- N
- hipred_score
- 0.305
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.571
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Leprotl1
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- late endosome to vacuole transport via multivesicular body sorting pathway;negative regulation of protein localization to cell surface
- Cellular component
- endosome;integral component of membrane
- Molecular function
- protein binding